PCSK9 levels and diabetic retinopathy: opportunities for a potential target and novel therapeutic approach in conjunction with treating dyslipidaemia
Affiliation
University of Sheffield Medical; Royal Hallamshire Hospital; University Hospitals of North Midlands NHS Trust; Keele University; University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; Aston University; Birmingham, Solihull and Black Country Diabetic Eye Screening ProgrammePublication date
2024-12-02
Metadata
Show full item recordAbstract
No abstract availableCitation
Varughese MS, Nayak AU, Jacob S. PCSK9 levels and diabetic retinopathy: opportunities for a potential target and novel therapeutic approach in conjunction with treating dyslipidaemia. Eye (Lond). 2024 Dec 2. doi: 10.1038/s41433-024-03523-1. Epub ahead of print.Type
ArticleAdditional Links
https://www.nature.com/eye/PMID
39623109Journal
EyePublisher
Nature Publishing Groupae974a485f413a2113503eed53cd6c53
10.1038/s41433-024-03523-1